CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.

 

Menu
Begin main content
Home Search
Result Type
Evidence Bundles
Product Line
Body Systems
Disease and Conditions
Target Population
Technologies, Therapies and Systems
Testing and Diagnostics
Publication Date
Clear all filters

Reports

We found 6032 result(s)

indacaterol /mometasone furoate (Atectura Breezhaler)

Last Updated: May 26, 2020
Result type: Reports
Product Line: Common Drug Review
Generic Name: indacaterol /mometasone furoate
Indications: Asthma maintenance (adults, children 12 or older)

  • Brand Name: Atectura Breezhaler
  • Manufacturer: Novartis Pharmaceuticals Canada Inc.
  • Project Number: SR0646-000
  • Project Status: Received
  • Submission Type: New
Details

dupilumab (Dupixent)

Last Updated: May 25, 2020
Result type: Reports
Product Line: Common Drug Review
Generic Name: dupilumab
Indications: atopic dermatitis

  • Brand Name: Dupixent
  • Manufacturer: Sanofi Genzyme, a division of sanofi-aventis Canada Inc.
  • Project Number: SR0636-000
  • Project Status: Active
  • Submission Type: New
Details

sacubitril/valsartan (Entresto)

Last Updated: May 26, 2020
Result type: Reports
Product Line: Common Drug Review
Generic Name: sacubitril/valsartan
Indications: Heart failure, NYHA Class II or III

  • Brand Name: Entresto
  • Manufacturer: Novartis Pharma Inc.
  • Project Number: SR0644-000
  • Project Status: Received
  • Submission Type: Resubmission
Details

icosapent ethyl (Vascepa)

Last Updated: May 26, 2020
Result type: Reports
Product Line: Common Drug Review
Generic Name: icosapent ethyl
Indications: Ischemic events in statin-treated patients

  • Brand Name: Vascepa
  • Manufacturer: HLS Therapeutics
  • Project Number: SR0619-000
  • Project Status: Active
  • Submission Type: New
Details

belimumab (Benlysta )

Last Updated: May 26, 2020
Result type: Reports
Product Line: Common Drug Review
Generic Name: Belimumab
Indications: systemic lupus erythematosus

  • Brand Name: Benlysta
  • Manufacturer: GlaxoSmithKline Inc.
  • Project Number: SR0616-000
  • Project Status: Active
  • Submission Type: New
Details

onasemnogene abeparvovec (Zolgensma)

Last Updated: May 26, 2020
Result type: Reports
Product Line: Common Drug Review
Generic Name: onasemnogene abeparvovec
Indications: Spinal muscular atrophy (SMA), pediatrics

  • Brand Name: Zolgensma
  • Manufacturer: Novartis Pharmaceuticals Canada Inc.
  • Project Number: SG0649-000
  • Project Status: Pending
  • Submission Type: New
Details